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Mutations in CNNM4 Cause Recessive Cone-Rod
Dystrophy with Amelogenesis Imperfecta
Bozena Polok,1,2,9 Pascal Escher,1,2,9 Aude Ambresin,2,3 Eliane Chouery,4 Sylvain Bolay,1
Isabelle Meunier,5 Francis Nan,5 Christian Hamel,5 Francis L. Munier,2,3 Bernard Thilo,6
Andre´ Me´garbane´,4,7 and Daniel F. Schorderet1,2,8,*
Cone-rod dystrophies are inherited dystrophies of the retina characterized by the accumulation of deposits mainly localized to the cone-
rich macular region of the eye. Dystrophy can be limited to the retina or be part of a syndrome. Unlike nonsyndromic cone-rod dystro-
phies, syndromic cone-rod dystrophies are genetically heterogeneous with mutations in genes encoding structural, cell-adhesion, and
transporter proteins. Using a genome-wide single-nucleotide polymorphism (SNP) haplotype analysis to ﬁne map the locus and a gene-
candidate approach, we identiﬁed homozygous mutations in the ancient conserved domain protein 4 gene (CNNM4) that either
generate a truncated protein or occur in highly conserved regions of the protein. Given that CNNM4 is implicated in metal ion trans-
port, cone-rod dystrophy and amelogenesis imperfecta may originate from abnormal ion homeostasis.Cone-rod dystrophy (CRD) can be either syndromic or
nonsyndromic. Nonsyndromic CRD is due to mutations
in genes implicated in photoreceptor function and devel-
opment, synaptic transmission or structure, retinoid
metabolism, and opsin trafﬁcking.1 CRD also occurs in
syndromes such as Bardet-Biedl (MIM 209900),2 thia-
mine-responsive megaloblastic anemia (Rogers syndrome
[MIM 249270]),3 or spinocerebellar ataxia type 7 (MIM
164500).4 In rare instances, it has been associated with dys-
morphic syndromes or metabolic dysfunctions.1 Recently,
a new autosomal-recessive syndrome associating CRD and
amelogenesis imperfecta (AI) has been described5 and
mapped to human chromosome 2q116,7 (MIM 217080).
Using ﬁne mapping of this chromosomal region, we
report the identiﬁcation of mutations in CNNM4 in three
families with CRD and AI. Blood was collected from
probands and affected and nonaffected ﬁrst-degree family
members after informed consent was obtained, and DNA
was isolated from peripheral leukocytes. The affected
family members had a complete eye and dental evalua-
tion, including best-corrected Snellen visual acuity
(BCVA), slit-lamp examination, funduscopy, Goldmann
perimetry, electroretinography (ERG), optical coherence
tomography (OCT), fundus color pictures, and autoﬂuor-
escence. Affected members were carefully assessed by
a dentist. The parents and unaffected siblings had
a complete physical evaluation, including best-vision
and fundus evaluation and dental inspection. The
protocol of the study adhered to the provisions of the
Declaration of Helsinki.
Family A, originating from Kosovo, is a two-generation
family with no history of consanguinity that was assessed
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Thesiblings showed poor vision (Figure 1A). The children
were ﬁrst seen in our hospital when they were 14 (II:1)
and 7 years of age (II:4), respectively. Both patients com-
plained of photophobia and showed pendular nystagmus.
They were highly hypermetropic and had low visual acuity
(II:1 right eye [RE]: 20/200, left eye [LE]: 20/100; II:4 both
eyes [BE]: 20/320). Both patients’ fundi showed optic
disk pallor, narrow vessels, macular atrophy with pigment
mottling, and peripheral deep white dot deposits mainly in
the lower and nasal retina. Patient II.1, who is functionally
less affected, did present peripheral bone spicules
(Figure 2A) concomitant with a superior and temporal
scotoma on static perimetry. Fundus autoﬂuorescence in
the same patient showed amarkedly decreasedmacular au-
toﬂuorescence due to atrophy as well as severe retinal
pigment epithelium (RPE) changes in the inferior and
nasal peripheral retina with levels of increased and
decreased autoﬂuorescence (Figure 2B). OCT showed
decreased foveal and retinal thickness, attenuation of
retinal lamination suggesting extensive loss of retinal cells,
and hyperreﬂectivity in the choroids due to RPE and cho-
riocapillaris atrophy (Figure 2C). The OCT device that
was used is not sensitive enough for evaluating any
ganglion cell loss. Full-ﬁeld photopic ERGs performed ac-
cording to protocols recommended by the International
Society for Clinical Electrophysiology of Vision (ISCEV)
were nonrecordable. Under scotopic conditions, b-wave
amplitudes were markedly reduced in patient II.1 and
severely reduced in patient II.4. A slightly delayed culmina-
tion time of the b-wave was observed in both patients.
During the 7 year follow up of patient II.1, the remaining
scotopic b-wave dropped by 40% of the lower limit for
the age. At the same time, both children were followedt of Ophthalmology, University of Lausanne, 1004 Lausanne, Switzerland;
Me´dicale, Faculty of Medicine, Universite´ Saint-Joseph, Beirut 1104-2020,
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Figure 1. Pedigrees of Family A and B and Electropherograms
(A and B) Pedigree of family A (A) and B (B). Filled symbols represent affected individuals, and open symbols represent unaffected indi-
viduals.
(C–E) Partial electropherograms of heterozygous (left) and homozygous (right) patients from family A showing the c.1312 dupC, family B
showing the c.707G/A (p.R236Q), and family C showing the c.971T/C (p.L324P) mutations in CNNM4, respectively.
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The American Journal of Human Genetics (2009), doi:10.1016/j.ajhg.2009.01.006by a dentist for AI (Figure 2D). In both children, the
decidual and permanent teeth were affected. The teeth
were dysplastic and yellow and brown in color, showing
no enamel layer and numerous carious lesions. In addi-2 The American Journal of Human Genetics 84, 1–7, February 13, 200tion, patient II.4 had a mandibular cyst that contained
the two lower incisors and one premolar.
Family B is a ﬁve-generation consanguineous family
originating from Lebanon (Figure 1B). Two sisters and9
Figure 2. Clinical Findings in Family A
(A) Fundus photograph (patient II.1)
showing optic disk pallor, narrow vessels,
macular atrophy with pigment mottling,
and peripheral spicules.
(B) Fundus autofluorescence (patient II.1)
showing markedly decreased macular auto-
fluorescence due to atrophy as well as
severe RPE changes in the inferior and
nasal peripheral retina with levels of
increased and decreased autofluorescence.
(C) OCT (patient II.4) showing decreased
foveal and retinal thickness, loss of well-
defined retinal layers suggesting extensive
loss of retinal cells, and hyperreflectivity in
the choroids due to the RPE and chorioca-
pillaris atrophy.
(D) Photograph of mouth (patient II.1)
showing dysplastic teeth with yellow and
brown discoloration characteristic of ame-
logenesis imperfecta. Upper incisor has
been accidentally removed.
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bling that affecting patients from family A. At age 2
months, a bilateral nystagmus was noted by the parents.
At age 2 years, the patients’ major complaints were the
presence of photophobia and difﬁculties seeing in dark-
ness. The decidual and permanent teeth were yellow and
brown, showing no enamel layer, with numerous carious
lesions in case of the two sisters, consistent with a hypo-
plastic, hypomineralized AI. ERG examination of patient
V.6 at 2 years according to ISCEV standards showed that
the scotopic response was within the normal range,
whereas the photopic response was severely attenuated.
Ophthalmological examination of both affected sisters
at age 12 and 6, respectively, revealed bilateral rapid
nystagmus and low vision. Full-ﬁeld photoscopic ERG
was nonrecordable. Under scotopic conditions, ERG
responses showed markedly reduced b-wave amplitudes.
The patient from family C is the only affected individual.
She was ﬁrst seen at the outpatient clinic at the age of 38
years. There was no history of eye disease in her family.
Her parents were not known to be related. At age 6, she
was legally blind (visual acuity 10/200 on both eyes) and
had a very intense photoaversion that caused difﬁculties
in moving in daylight. However, in dim light, she could
move easily and was able to read. She could see only satu-
rated colors. By age 9, she was placed in a special school
for sight-disabled children. At adolescence, she lost her
central vision. By age 16, she became night blind and
started to have difﬁculties in moving in dim light. By age
20, she was severely handicapped. She had abnormal
enamel from early childhood. She rapidly lost her milkTheteeth, and she then had severe alteration of the enamel on
her adult teeth. At age 24, she had a very signiﬁcant erosion
of all teeth with absence of enamel, resulting in a dark
yellow color, hypersensitivity, and teeth cavities. For this
reason, all teeth were devitalized and capped with ceramic
prostheses. At the time of presentation, her vision was
limited to light perception on both eyes. Refractionwas ob-
tained only on LE: 1.25 (15; 1.50). She had bilateral
subcapsular posterior cataract. Intraocular pressure was
normal at 18 mm Hg on both eyes. The fundus showed
a bilateralmacular atrophy and typical bone spicule-shaped
pigment deposits in themidperiphery of the retina. Retinal
vasculature was highly attenuated, and optic discs were
pale. Therewas no detectable visual ﬁeld atGoldmannperi-
metry. The ISCEV ERG showed no response. Neurological
and cognitive examination was normal in all patients.
Whole-genome linkage analysis was performed on
family A at the DNA array facility of the University of Lau-
sanne with the Affymetrix human mapping 50K XbaI
array according to the manufacturer’s protocols. Regions
of homozygosity were identiﬁed and plotted with the
web site LodIRO. When present, these regions included
adjacent noninformative homozygous single nucleotide
polymorphism(s) (SNP). Eight homozygous regions larger
than 3 Mb were observed (Figure S1 available online).
One region spanned the centromere of chromosome 2
from rs2970925 to rs953320, leaving an effective homozy-
gous region of approximately 5.4 Mb that overlapped the
previously reported linked region for this disease6
(Figure S1). We therefore focused our attention on the
genes in this region.American Journal of Human Genetics 84, 1–7, February 13, 2009 3
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Figure 3. CNNM4 Immunostaining of
Mouse Cornea and Retina
CNNM4 immunostaining of cornea (A–C)
and retina (D–F) of 2-month-old mouse
retina. In the cornea (B), CNNM4 is
mainly localized in the epithelium (epi)
surrounding the nuclei, in the keratocyte
present in the stroma (st), and in the endo-
thelium (en). (A) shows DAPI staining of
the same slide, and (C) shows negative
control without primary antibody. In the
retina (E), immunostaining is mainly local-
ized in the ganglion cell layer (indicated by
the arrow), the inner and outer plexiform
layers, and the outer segments of the
photoreceptors. (D) shows DAPI staining
of the same slide, and (F) shows negative
control of without primary antibody. Symbols are used as follows: arrow, ganglion cell layer; asterisk, inner cell layer; filled triangle, outer
cell layer; triangle, retinal pigment epithelium. The rabbit polyclonal antibody raised against amino acids 21–200 of human CNNM4 was
used in a 1:200 dilution on 12 mm cryosections of eyes of 2-month-old C57Bl/6 mice. Secondary antibodies conjugated to Alexa Fluor 594
(Molecular Probes, Invitrogen) were diluted at 1:1000. Sections were stained with DAPI for visualizing nuclei before mounting in Cityfluor
(Cityfluor Ltd.).
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homology to genes previously implicated in eye diseases,
but none showed sequence variants that could be respon-
sible for the observed phenotype.We then looked for genes
coding for transcription factors and transporters expressed
in eyes and teeth. A list of sequenced genes can be found in
Table S1. Sequencing the coding regions of ancient
conserved domain protein 4 (CNNM4 [MIM 607805]),
a metal transporter, showed a homozygous one-base-pair
duplication (c.1312 dupC;þ1 being the A of ATG transla-
tion start) present in both affected siblings. This duplica-
tion creates a frameshift and a new putative stop codon
nine residues downstream (p.L438Pfs9X) (Figure 1C). In
family B, sequencing the same exon identiﬁed a homozy-
gous c.707G/A transition inducing the modiﬁcation of
arginine 236 into a glutamine (p.R236Q) (Figure 1D) in
all three affected individuals. In family C, a homozygous
c.971T/C mutation inducing a leucine-to-proline muta-
tion at amino acid position 324 (p.L324P) (Figure 1E)
(primers and WAVE conditions for CNNM4 and mutations
can be found in Table S2). All parents were heterozygous
for their respective mutation. The missense mutations
were located in the transmembrane region of the protein,
Arginine 236 between the ﬁrst and second domain and
Leucine 324 just after the fourth. Arginine 236 and Leucine
324 are completely conserved among species as far as
C. elegans and in human and mouse paralogs (Figure S2).
These mutations were analyzed in ethnically matched con-
trol individuals and in 1248 index patients with various
forms of retinal degeneration. The c.1312 dupC mutation
wasobservedataheterozygousstate inonecontrol individual
coming from the same geographical region as family A. No
mutation was observed in the screened cohort of patients.
Immunohistochemical localization of CNNM4 was eval-
uated in retina of 2-month-old (2M) C57Bl/J6 mice with
a rabbit polyclonal antibody raised against amino acids4 The American Journal of Human Genetics 84, 1–7, February 13, 20021–200 of human CNNM4 obtained from Santa Cruz
Biotechnology. At 2M, a strong signal was observed in
the different parts of the eye (Figure 3). In the cornea,
CNNM4 localization was mainly observed in the epithe-
lium surrounding the nuclei, in the keratocytes, and in
the endoderm. In the retina, CNNM4 localization was
concentrated in the ganglion cell layers, the inner (IPLs)
and outer plexiform layers (OPLs), and the inner and outer
photoreceptor segments (Figure 3), where it was mainly
localized to the cytoplasm compartment, surrounding
the nucleus. IPLs and OPLs consist of connecting ﬁbrils
and dendrites from ganglion, bipolar, amacrine, Muller,
and horizontal cells and rod and cone photoreceptors.
The nuclei of the inner and outer cell layers as well as the
RPE also showed CNNM4 staining, but at a lower level.
This staining is consistent with the observation that
CNNM4 was localized in dendrites and soma of cultured
neurons.8
AI describes a group of inherited disorders primarily
affecting the formation of enamel, a tissue with low
protein and high mineral content. During tooth forma-
tion, ameloblasts secrete the four major matrix proteins
and proteases: amelogenin, ameloblastin, enamelin, and
enamelysin. Although this part of tooth development is
relatively well characterized, not much is known about
the maturation of enamel, during which the protein
content is slowly being reduced and the mineral content
is increased in order to produce enamel, the strongest
tissue of the body.9,10 Because CNNM4 is implicated in
ion transport,8,11 possibly of magnesium, the hypoplastic
and hypomineralized form of AI present in these families
could result from aberrant mineralization of enamel. We
therefore investigated the localization of CNNM4 in teeth
of postnatal day 2 (P2) mice by immunohistology. Staining
was observed ubiquitously in the tooth and was strongest
in the cell body of the ameloblasts (Figure 4). Transcription9
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Figure 4. CNNM4 Immunostaining of
Mouse Lower Incisor
Immunostaining of a lower incisor of a
2-day-old mouse. CNNM4 is localized in
all tissues of the mandibula, including
muscle and connective tissue (B). DAPI
staining of the same slide is shown in
(A), and negative control without primary
antibody is shown in (C). At higher magni-
fication (4003), CNNM4 is observed in
the ameloblasts (indicated by the filled
triangle) and their cell body (indicated by
the open triangle) as well as in the odonto-
blasts (indicated by the asterisk) (E). (D)
shows DAPI staining of the same slide,
and (F) shows negative control without
secondary antibody.
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conﬁrmed by reverse transcriptase-polymerase chain reac-
tion. In addition, we evaluated by quantitative PCR the
relative levels of expression between the four members of
the CNNM family in brain and eye. Notably, Cnnm4 was
at its highest expression levels in the retina, whereas
Cnnm1, Cnnm2, and Cnnm3 mRNA expression was mark-
edly higher in brain than in retina (Figure S3).
CNNM4 is characterized by an ‘‘ancient conserved
domain’’ that is evolutionarily conserved in species
ranging from bacteria to zebraﬁsh to mammals.11 We
therefore evaluated in zebraﬁsh the effect of a morpholino
(MO)-based knockdown expression of cnnm4 that poten-
tially mimicked the loss-of-function mutation observed
in family A. From 1 to 3 days postfertilization (dpf), tran-A B C
D
the T7 promoter. Forty pg of mRNA were injected in eggs together w
ganglion cell layers (GCLs) was counted on toluidine blue-stained s
embryos was set to 1, and the counts in the morphants and rescued
Thesient tachycardia was observed in most of the embryos
treated with MO. This tachycardia was not observed
anymore at 5 dpf. At that stage, the eyes of the morphants
showed a reduction of approximately 35% of the number
of ganglion cells on toluidine blue-stained sections. This
reduction was rescued by approximately 50% with injec-
tion of human CNNM4 mRNA (Figure 5). Zebraﬁsh do
not have buccal teeth, but instead have two sets of pharyn-
geal teeth. Tooth initiation occurs approximately 36 to
48 hr postfertilization (hpf), and the ﬁrst two germs (I1
and I2) become mineralized by 3 and 5 dpf, respectively,
12
at a time when morpholinos reach their limit of action.
Zebraﬁsh teeth were therefore not examined.
CNNM proteins are also known under the name of
ACDP1 to 4 and cyclin M1 to 4. The 775 amino acidFigure 5. Toluidine Blue-Staining Sec-
tions of a Zebrafish Eye
Toluidine blue-stained sections of 5 dpf
zebrafish embryos.
(A) Wild-type embryos.
(B) Morphant embryos.
(C) Rescued embryos.
(D) Ganglion cell number was quantified in
the indicated zebrafish eye and then
compared to wild-type set to 1 (n¼ 12
eyes in each category). The following
abbreviations were used: WT, wild-type;
MO, morpholino-treated embryos; rescue,
morpholino-treated embryos injected with
CNNM4 mRNA. Morpholinos were designed
for targeting the exon 2-intron 2 splice
site. One hundred micromolar solutions of
either cnnm4 morpholino (MO: ATTTT
GCCAC TGTCC ACTCA CTGTA) or control-mor-
pholino (ct-MO: ATaTT cCCAC TcTCC ACTgA
CTcTA) were injected into the eggs at the
1–2 cell stage. In rescue experiments, the
human full-length CNNM4 cDNA was subcl-
oned in pCDNA3.1 and transcribed from
ith the MO. Embryos were evaluated at 5 dpf, and the number of
ections containing the optic nerve. The number of GCLs from WT
embryos were compared. Bars represent standard errors.
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a sequence motif present in cyclin box, a cyclic nucleo-
tide-monophosphate (cNMP)-binding domain, two cysta-
thionine-beta-synthase (CBS) domains, and a DUF21
domain.11 CBS domains are small intracellular modules,
usually found in two or four copies, and their function is
still debated.13 Proteins with CBS domains have been
implicated as metabolic sensors (Cystathionine beta-syn-
thase) and also implicated in ATP binding (AMP-activated
protein kinase), nucleotide biosynthesis (inosine-50-mono-
phosphate dehydrogenase, IMPDH), and intracellular traf-
ﬁcking and protein-protein interactions (CLC family).13
Interestingly, mutations in IMPDH1 (OMIM: 146690) and
in the gamma-2 regulatory subunit of AMP-activated
protein kinase (MIM 602643) cause retinitis pigmentosa
(RP10 [MIM 180105])14 and familial hypertrophic cardio-
myopathy with Wolff-Parkinson-White syndrome (MIM
600858),15 respectively.
Although the exact function ofCNNM4 is still unknown,
several members of this family have been investigated. In
bacteria, CorC, formed by the highly conserved core
protein region of all CNNM, is involved in magnesium
and cobalt efﬂux,11 whereas in Saccharamyces cerevisiae,
Mam3p, anortholog ofCNNM4, is implicated inmanganese
toxicity.16 CNNM4 is expressed in many tissues, and recent
studies on spinal cord dorsal hornneuronshave shown that
it is located on or close to the plasma membrane, where it
interacts with cytochrome oxydase 11 (COX11 [MIM
603648]) to regulate metal ion homeostasis.8 Metal ions
are indispensable to many physiological processes, in
particular to the visual cycle, in which, among other func-
tions, magnesium is critical for adjusting the Ca2þ sensi-
tivity of the membrane guanylate cyclase 2D (GUCY2D
[MIM 600179]), an enzyme that produces cGMP in photo-
receptor cells when stimulated by guanylyl cyclase-acti-
vating protein-1 (GUCA1A [MIM 600364]). Under physio-
logical conditions, activation of photoreceptor GUCY2D
is caused by Mg2þ and Ca2þ exchange in the EF-hands of
GCAP1. Mutations in GUCY2D and GUCA1A have been
associated with CRD (MIM 601777)17 and with congenital
amaurosis, a severe form of CRD (MIM 204000),18 and
cone dystrophy (MIM 600364), respectively.19 Magnesium
is also essential in enamel formation. It is found at high
concentrations in enamel ﬂuid surrounding the forming
enamel crystals, where it can compete with Ca ions for
adsorption onto these crystals.20
This study identiﬁes mutations in the CNNM4 gene that
result in the autosomal-recessive CRD with AI. The nature
of the mutations suggests a loss-of-function mechanism
and paves the way to a new therapeutic approach by
viral-mediated gene replacement. It also highlights a new
gene involved in the maturation of amelogenin, a gene
that will be of some importance in understanding the
development of caries.
The experiments performed in animals adhered to the
Association for Research in Vision and Ophthalmology
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